Inactief instrument

Andere talen Regenicin, Inc. Other OTC

Aandelen

RGIN

US75887Q1022

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Regenicin, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023	15-05-23
REGENICIN, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	13-02-23
Regenicin, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2022	13-02-23
REGENICIN, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	13-01-23
Regenicin, Inc. Reports Earnings Results for the Full Year Ended September 30, 2022	13-01-23
REGENICIN, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	12-08-22
Regenicin, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2022	12-08-22
REGENICIN, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	23-05-22
Regenicin, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2022	23-05-22
REGENICIN, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q/A)	25-03-22
REGENICIN, INC. - 10-K/A - Management's Discussion and Analysis of Financial Condition and Results of Operations	25-03-22
REGENICIN, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	14-02-22
Regenicin, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2021	14-02-22
REGENICIN, INC. - 10-K/A - Management's Discussion and Analysis of Financial Condition and Results of Operations	08-02-22
REGENICIN, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	13-01-22
Regenicin, Inc. Reports Earnings Results for the Full Year Ended September 30, 2021	13-01-22
REGENICIN : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	23-08-21
Regenicin, Inc. Reports Earnings Results for the Third Quarter Ended June 30, 2021	23-08-21
REGENICIN : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	17-05-21
Regenicin, Inc. Reports Earnings Results for the Second Quarter Ended March 31, 2021	17-05-21

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Regenicin, Inc. Other OTC

Aandelen

RGIN

US75887Q1022

Andere talen

Filters